Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID) historically utilized to treat conditions such as osteoarthritis, rheumatoid arthritis, acute pain, migraines, and dysmenorrhea.… Read more
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID) historically utilized to treat conditions such as osteoarthritis, rheumatoid arthritis, acute pain, migraines, and dysmenorrhea. This category provides access to high-quality pharmaceutical reference standards and stable isotope labelled compounds essential for rigorous analytical testing and method validation. Laboratories utilize these materials for accurate impurity profiling and to support stability-indicating HPLC analysis during the quality control of pharmaceutical formulations. The availability of Rofecoxib alongside its deuterated analogs, such as Rofecoxib-d5, allows researchers and analytical chemists to perform precise quantification and identification of degradation products or metabolites. These reference materials are critical for ensuring compliance with regulatory standards and maintaining the accuracy of assay results in developmental and investigative studies involving this nonsteroidal anti-inflammatory agent.